Kimberly Lenz, PharmD, clinical pharmacy manager, MassHealth/Office of Clinical Affairs, University of Massachusetts Medical School discusses initiatives introduced to implement appropriate opioid prescribing, best practices for enforcing appropriate prescribing, and if current opioid restrictions have reduced utilization.
Kimberly Lenz, PharmD, clinical pharmacy manager, MassHealth/Office of Clinical Affairs, University of Massachusetts Medical School discusses initiatives introduced to implement appropriate opioid prescribing, best practices for enforcing appropriate prescribing, and if current opioid restrictions have reduced utilization.
Transcript
What initiatives have been introduced to implement appropriate opioid prescribing?
When you look across both our plan, as well as other plans across the nation, I think the majority of health plans implement dose limits, quantity limits, duplicate restrictions, and things of that nature, but it really is a wide variety of different plans and initiatives that plans use. Other plans, like ours, use a therapeutic class management program where a multidisciplinary team comes together to reach out to prescribers and discuss treatment plans.
What are best practices to enforce appropriate opioid prescribing?
I think most programs end up using prior authorization because inevitably that’s the tool we have to use, but I think the best approach really is using that in combination with that multidisciplinary team, who’s going to work with the provider hand in glove to kind of decide on safe prescribing, as well as what they think is best for the patient.
Have current opioid restrictions decreased opioid utilization?
It’s a great question, and I’m glad you asked that, because we actually just looked at that in our program. So, I can speak directly to our program, and yes it has worked. So, when we looked over the last 15 years, with our partners at the drug utilization review program at UMass Medical School, we did find a sustained decrease in the average daily dose of our patients who were on high doses of opioids after 3 sequential dose reductions. So right now, we have a high dose limit of 120mg of morphine equivalents, and again, over those 15 years we did see sustained decreases.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
CMS Leaders Describe Their Partnership to Align Programs, Address ACOs’ Concerns
April 11th 2024As CMS’ suite of value-based and accountable care models evolves, leaders from across the agency detailed how they are working together to streamline quality reporting and encourage the move to a population health mindset while addressing providers’ concerns.
Read More